» Articles » PMID: 37234033

Accuracy of a Standalone Atrial Fibrillation Detection Algorithm Added to a Popular Wristband and Smartwatch: Prospective Diagnostic Accuracy Study

Overview
Publisher JMIR Publications
Date 2023 May 26
PMID 37234033
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Silent paroxysmal atrial fibrillation (AF) may be difficult to diagnose, and AF burden is hard to establish. In contrast to conventional diagnostic devices, photoplethysmography (PPG)-driven smartwatches or wristbands allow for long-term continuous heart rhythm assessment. However, most smartwatches lack an integrated PPG-AF algorithm. Adding a standalone PPG-AF algorithm to these wrist devices might open new possibilities for AF screening and burden assessment.

Objective: The aim of this study was to assess the accuracy of a well-known standalone PPG-AF detection algorithm added to a popular wristband and smartwatch, with regard to discriminating AF and sinus rhythm, in a group of patients with AF before and after cardioversion (CV).

Methods: Consecutive consenting patients with AF admitted for CV in a large academic hospital in Amsterdam, the Netherlands, were asked to wear a Biostrap wristband or Fitbit Ionic smartwatch with Fibricheck algorithm add-on surrounding the procedure. A set of 1-min PPG measurements and 12-lead reference electrocardiograms was obtained before and after CV. Rhythm assessment by the PPG device-software combination was compared with the 12-lead electrocardiogram.

Results: A total of 78 patients were included in the Biostrap-Fibricheck cohort (156 measurement sets) and 73 patients in the Fitbit-Fibricheck cohort (143 measurement sets). Of the measurement sets, 19/156 (12%) and 7/143 (5%), respectively, were not classifiable by the PPG algorithm due to bad quality. The diagnostic performance in terms of sensitivity, specificity, positive predictive value, negative predictive value, and accuracy was 98%, 96%, 96%, 99%, 97%, and 97%, 100%, 100%, 97%, and 99%, respectively, at an AF prevalence of ~50%.

Conclusions: This study demonstrates that the addition of a well-known standalone PPG-AF detection algorithm to a popular PPG smartwatch and wristband without integrated algorithm yields a high accuracy for the detection of AF, with an acceptable unclassifiable rate, in a semicontrolled environment.

Citing Articles

Diagnostic accuracy of ECG smart chest patches versus PPG smartwatches for atrial fibrillation detection: a systematic review and meta-analysis.

Sibomana O, Hakayuwa C, Obianke A, Gahire H, Munyantore J, Chilala M BMC Cardiovasc Disord. 2025; 25(1):132.

PMID: 40000931 PMC: 11853970. DOI: 10.1186/s12872-025-04582-2.


Performance of a medical smartband with photoplethysmography technology and artificial intelligence algorithm to detect atrial fibrillation.

Blok S, Gielen W, Piek M, Hoeksema W, Tulevski I, Somsen G Mhealth. 2025; 11:5.

PMID: 39944860 PMC: 11811644. DOI: 10.21037/mhealth-24-10.


Evaluation of the performance and reliability of a smartwatch capable of performing ECGs: A prospective observational study.

Kader F, Bayramoglu B, Tayfur I Heliyon. 2025; 11(1):e41682.

PMID: 39866437 PMC: 11760325. DOI: 10.1016/j.heliyon.2025.e41682.


Wristwatch pulse wave monitoring: assessing daily activity post-catheter ablation for atrial fibrillation.

Nonoguchi N, Soejima K, Katsume Y, Hoshida K, Togashi I, Goda A Eur Heart J Digit Health. 2025; 6(1):96-103.

PMID: 39846064 PMC: 11750189. DOI: 10.1093/ehjdh/ztae091.


A Scoping Review of the Use of Artificial Intelligence in the Identification and Diagnosis of Atrial Fibrillation.

Junior A, E Silva A, E Silva L, de Lima K, de Oliveira H J Pers Med. 2024; 14(11).

PMID: 39590561 PMC: 11595485. DOI: 10.3390/jpm14111069.


References
1.
Kirchhof P, Blank B, Calvert M, Camm A, Chlouverakis G, Diener H . Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH-AFNET 6) trial. Am Heart J. 2017; 190:12-18. PMC: 5546174. DOI: 10.1016/j.ahj.2017.04.015. View

2.
Svennberg E, Friberg L, Frykman V, Al-Khalili F, Engdahl J, Rosenqvist M . Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial. Lancet. 2021; 398(10310):1498-1506. DOI: 10.1016/S0140-6736(21)01637-8. View

3.
Zoni-Berisso M, Lercari F, Carazza T, Domenicucci S . Epidemiology of atrial fibrillation: European perspective. Clin Epidemiol. 2014; 6:213-20. PMC: 4064952. DOI: 10.2147/CLEP.S47385. View

4.
Perez M, Mahaffey K, Hedlin H, Rumsfeld J, Garcia A, Ferris T . Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation. N Engl J Med. 2019; 381(20):1909-1917. PMC: 8112605. DOI: 10.1056/NEJMoa1901183. View

5.
Reiffel J, Verma A, Kowey P, Halperin J, Gersh B, Wachter R . Incidence of Previously Undiagnosed Atrial Fibrillation Using Insertable Cardiac Monitors in a High-Risk Population: The REVEAL AF Study. JAMA Cardiol. 2017; 2(10):1120-1127. PMC: 5710506. DOI: 10.1001/jamacardio.2017.3180. View